In our study, all of our HCAs represent a clonally propagated lesion with respective genetic alterations in the APC gene and thus a specific manifestation of FAP—irrespective of coexisting known risk factors for HCA—since we identified mutational inactivation of the second allele in all FAP-HCAs analyzed. The gene discussed is FAP; the disease is hepatocellular adenoma.